The role of the FDA in drug development: implications for improved access to new HIV/AIDS therapies. Testimony before the Subcommittee on Health and Environment-Committee on Commerce concerning FDA reform bill HR 3199.
Cooper
E C
EC
Department of Clinical Research and Information, American Foundation for AIDS Research, USA.
Sanders
S
S
D004059:Diffusion of Innovation; D017277:Drug Approval / Q000458:organization & administration*; D015658:HIV Infections / Q000628:therapy*; D018166:Health Care Reform / Q000331:legislation & jurisprudence; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence; D006801:Humans; D007255:Information Services; D009936:Organizational Innovation; D012107:Research Design / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*